Lucence Diagnostics Private
Latest round
- Series A
Last raised
- Sep 2018
Total raised
- $9.2M
Investors
- 4
About Lucence Diagnostics Private
Based in Singapore, and founded in 2016, Lucence Life Sciences Pte. Ltd is a company that develops technology for early cancer detection. The company uses a deep genome intelligence created by different professionals from fields such as oncology, laboratory medicine, technology development, and data science. The firm has offices in San Francisco, Hong Kong, and Suzhou
Who invested in Lucence Diagnostics Private
4 investors across 1 round
See all investors in Lucence Diagnostics Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 20, 2018
Amount
$9.2M
Investors
Questions about Lucence Diagnostics Private
Who invested in Lucence Diagnostics Private?
Lucence Diagnostics Private has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lucence Diagnostics Private raised?
Lucence Diagnostics Private has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lucence Diagnostics Private last raise money?
Lucence Diagnostics Private's most recent round on record is a Series A, in Sep 2018.
What does Lucence Diagnostics Private do?
Based in Singapore, and founded in 2016, Lucence Life Sciences Pte.
Where is Lucence Diagnostics Private headquartered?
Lucence Diagnostics Private is headquartered in Singapore, Singapore.
Which VCs invest in companies like Lucence Diagnostics Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Lucence Diagnostics Private's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Lucence Diagnostics Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.